Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Cardiology
Published in: Pediatric Cardiology 1/2017

01-01-2017 | Case Report

Atrial Septal Defect Closure with Occlutech® ASD Fenestrated Device in a Child with Severe Pulmonary Hypertension

Authors: Francisco Gonzalez-Barlatay, Anne Fournier, Marie-Josée Raboisson, Nagib Dahdah

Published in: Pediatric Cardiology | Issue 1/2017

Login to get access

Abstract

We report a 5-year-old patient with severe pulmonary hypertension and a large secundum atrial septal defect who benefited from a percutaneous closure of the defect with an Occlutech® custom-made fenestrated device. Whereas the closure is technically identical to standard atrial defect closure, the immediate and midterm beneficial results are presented.
Literature
1.
Schwerzmann M, Zafar M, McLaughlin PR, Chamberlain DW, Webb G, Granton J (2006) Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy. Int J Cardiol 110(1):104–107CrossRefPubMed
2.
Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ (2013) Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension. Cardiol Young 23(05):692–696CrossRefPubMed
3.
Kretschmar O, Sglimbea A, Corti R, Knirsch W (2010) Shunt reduction with a fenestrated Amplatzer device. Catheter Cardiovasc Interv 76(4):564–571CrossRefPubMed
4.
Schneider HE, Jux C, Kriebel T, Paul T (2011) Fate of a modified fenestration of atrial septal occluder device after transcatheter closure of atrial septal defects in elderly patients. J Interv Cardiol 24(5):485–490CrossRefPubMed
5.
Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV (2004) American College of Chest Physicians. Medical therapy for pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest 126(Suppl. 1):35S–62SCrossRefPubMed
6.
van Riel AC, Blok IM, Zwinderman AH, Wajon EM, Sadee AS, Bakker-de Boo M, van Dijk AP, Hoendermis ES, Riezebos RK, Mulder BJ, Bouma BJ (2015) Lifetime risk of pulmonary hypertension for all patients after shunt closure. J Am Coll Cardiol 66(9):1084–1086CrossRefPubMed
7.
8.
Ammar RI, Hegazy RA (2013) Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age. J Invasive Cardiol 25(2):76–79PubMed
Metadata
Title
Atrial Septal Defect Closure with Occlutech® ASD Fenestrated Device in a Child with Severe Pulmonary Hypertension
Authors
Francisco Gonzalez-Barlatay
Anne Fournier
Marie-Josée Raboisson
Nagib Dahdah
Publication date
01-01-2017
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 1/2017
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-016-1530-4

Other articles of this Issue 1/2017

Pediatric Cardiology 1/2017 Go to the issue

Original Article

Evaluation of Residual Coarctation in Infants with a Single Right Ventricle after Stage I Palliation

Original Article

Optimal Transducer Level for Atrial and Pulmonary Arterial Pressure Measurement in Patients with Functional Single Ventricle

Case Report

Emergency Pacing via the Umbilical Vein and Subsequent Permanent Pacemaker Implantation in a Neonate

Original Article

Galectin-3 in Children with Chronic Heart Failure with Normal and Reduced Ejection Fraction: Relationship to Disease Severity

Original Article

High g-Force Rollercoaster Rides Induce Sinus Tachycardia but No Cardiac Arrhythmias in Healthy Children

Original Article

Utility and Scope of Rapid Prototyping in Patients with Complex Muscular Ventricular Septal Defects or Double-Outlet Right Ventricle: Does it Alter Management Decisions?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits